These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18077164)

  • 1. Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide.
    Piergentili A; Quaglia W; Giannella M; Del Bello F; Buccioni M; Nesi M; Matucci R
    Bioorg Med Chem Lett; 2008 Jan; 18(2):614-8. PubMed ID: 18077164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation.
    Piergentili A; Quaglia W; Del Bello F; Giannella M; Pigini M; Barocelli E; Bertoni S; Matucci R; Nesi M; Bruni B; Di Vaira M
    Bioorg Med Chem; 2009 Dec; 17(24):8174-85. PubMed ID: 19896386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives.
    Dei S; Angeli P; Bellucci C; Buccioni M; Gualtieri F; Marucci G; Manetti D; Matucci R; Romanelli MN; Scapecchi S; Teodori E
    Biochem Pharmacol; 2005 Jun; 69(11):1637-45. PubMed ID: 15896343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists.
    Scapecchi S; Nesi M; Matucci R; Bellucci C; Buccioni M; Dei S; Guandalini L; Manetti D; Martini E; Marucci G; Romanelli MN; Teodori E; Cirilli R
    J Med Chem; 2008 Jul; 51(13):3905-12. PubMed ID: 18543900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dioxane and oxathiane nuclei: suitable substructures for muscarinic agonists.
    Piergentili A; Quaglia W; Giannella M; Del Bello F; Bruni B; Buccioni M; Carrieri A; Ciattini S
    Bioorg Med Chem; 2007 Jan; 15(2):886-96. PubMed ID: 17084634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 5-(4-alkylsulfanyl-[1, 2, 5]thiadiazol-3-yl)-3-methyl-1, 2, 3, 4-tetrahydropyrimidine oxalate salts and their evaluation as muscarinic receptor agonists.
    Jung MH; Park JG; Park WK
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):230-5. PubMed ID: 12916057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.
    Scapecchi S; Matucci R; Bellucci C; Buccioni M; Dei S; Guandalini L; Martelli C; Manetti D; Martini E; Marucci G; Nesi M; Romanelli MN; Teodori E; Gualtieri F
    J Med Chem; 2006 Mar; 49(6):1925-31. PubMed ID: 16539379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.
    Bromidge SM; Brown F; Cassidy F; Clark MS; Dabbs S; Hadley MS; Hawkins J; Loudon JM; Naylor CB; Orlek BS; Riley GJ
    J Med Chem; 1997 Dec; 40(26):4265-80. PubMed ID: 9435896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists.
    Del Bello F; Barocelli E; Bertoni S; Bonifazi A; Camalli M; Campi G; Giannella M; Matucci R; Nesi M; Pigini M; Quaglia W; Piergentili A
    J Med Chem; 2012 Feb; 55(4):1783-7. PubMed ID: 22243489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of novel derivatives of the muscarinic agonist tetra(ethylene glycol)(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether (CDD-0304): effects of structural modifications on the binding and activity at muscarinic receptor subtypes and chimeras.
    Tejada FR; Nagy PI; Xu M; Wu C; Katz T; Dorsey J; Rieman M; Lawlor E; Warrier M; Messer WS
    J Med Chem; 2006 Dec; 49(25):7518-31. PubMed ID: 17149881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    Bioorg Med Chem; 2008 May; 16(10):5490-500. PubMed ID: 18455407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
    Childers WE; Abou-Gharbia MA; Kelly MG; Andree TH; Harrison BL; Ho DM; Hornby G; Huryn DM; Potestio L; Rosenzweig-Lipson SJ; Schmid J; Smith DL; Sukoff SJ; Zhang G; Schechter LE
    J Med Chem; 2005 May; 48(10):3467-70. PubMed ID: 15887953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).
    Pallavicini M; Budriesi R; Fumagalli L; Ioan P; Chiarini A; Bolchi C; Ugenti MP; Colleoni S; Gobbi M; Valoti E
    J Med Chem; 2006 Nov; 49(24):7140-9. PubMed ID: 17125266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations.
    Wu WM; Wu J; Mori N; Buchwald P; Bodor N
    Pharmazie; 2008 Mar; 63(3):200-9. PubMed ID: 18444508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro pharmacology of novel heterocyclic muscarinic ligands.
    De Amici M; Conti P; Fasoli E; Barocelli E; Ballabeni V; Bertoni S; Impicciatore M; Roth BL; Ernsberger P; De Micheli C
    Farmaco; 2003 Sep; 58(9):739-48. PubMed ID: 13679167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mechanism of agonist efficacy: a relationship between efficacy and agonist dissociation rate at the muscarinic M3 receptor.
    Sykes DA; Dowling MR; Charlton SJ
    Mol Pharmacol; 2009 Sep; 76(3):543-51. PubMed ID: 19498041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and muscarinic activity of 1,2,3,4-tetrahydropyrimidine derivatives.
    Jung MH; Park JG; Yang KJ; Lee MJ
    Arch Pharm (Weinheim); 2001 Mar; 334(3):79-85. PubMed ID: 11315338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models.
    Malviya M; Kumar YC; Mythri RB; Venkateshappa C; Subhash MN; Rangappa KS
    Bioorg Med Chem; 2009 Aug; 17(15):5526-34. PubMed ID: 19595599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.